Back to Journals » International Journal of Nanomedicine » Volume 12

Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor control [Corrigendum]

Authors Shen YA, Shyu IL, Lu M, He CL, Hsu YM, Liang HF, Liu CP, Liu RS, Shen BJ, Wei YH, Chuang CM

Received 2 October 2017

Accepted for publication 2 October 2017

Published 2 November 2017 Volume 2017:12 Pages 8101—8102


Shen YA, Shyu IL, Lu M, et al. Int J Nanomedicine. 2015; 10:2485–2502.

The authors advise that Figure 2B on page 2490 contains the incorrect image for the EP group. The correct Figure 2B image is shown below.

Read the original article

Creative Commons License © 2017 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.